Dexamethasone with hypromellose, neomycin and polymyxin B sulfate
Brand names: Maxitrol
This is a combined ophthalmic preparation containing the corticosteroid dexamethasone, the lubricant hypromellose, and the antibiotics neomycin and polymyxin B sulfate, used for ocular surface inflammation where a bacterial infection is present or likely.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Dexamethasone suppresses ocular inflammation by inhibiting inflammatory mediators; neomycin (an aminoglycoside) and polymyxin B provide broad Gram-negative and some Gram-positive antibacterial cover, while hypromellose lubricates and prolongs contact time.
Prescribing in practice
- Topical corticosteroids must not be used in undiagnosed red eye or suspected herpes simplex (dendritic) keratitis, where they can cause rapid corneal melting and sight loss, so a herpetic cause must be excluded.
- Prolonged use risks steroid-induced glaucoma, cataract and masking or worsening of infection, so courses should be short and ophthalmologist-supervised.
- Neomycin is a frequent cause of contact hypersensitivity; discontinue if local allergic reaction develops.
Monitoring
With more than short-term use, monitor intraocular pressure and review the cornea and clinical response, stopping if infection worsens or hypersensitivity appears.
Counselling the patient
- Use only for the prescribed short course and do not keep using it for future eye problems.
- Stop and seek advice if the eye becomes more painful, red or swollen, which may indicate an allergy or worsening infection.
- Remove contact lenses during treatment unless your clinician advises otherwise.
Evidence & guidelines
Combined steroid-antibiotic eye preparations are well established for inflammatory eye conditions with a bacterial component, with safe use depending on excluding viral keratitis and limiting duration.
Reference: RCOphth; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Steroid Dose Equivalence · Medications
- Adrenal Crisis Risk Score · Adrenal Disorders
- Ideal Body Weight (Devine) · Anthropometry
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Apfel Score for Postoperative Nausea and Vomiting · Perioperative
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme